SRC and STAT3 Inhibitors Synergize to Promote Tumor Inhibition in Renal Cell Carcinoma

Oncotarget - United States
doi 10.18632/oncotarget.5971
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

SRC Activates Abl to Augment Robo1 Expression in Order to Promote Tumor Cell Migration

Oncotarget
Oncology
2010English

Simvastatin-Induced Cell Cycle Arrest Through Inhibition of STAT3/SKP2 Axis and Activation of AMPK to Promote P27 and P21 Accumulation in Hepatocellular Carcinoma Cells

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2017English

TNF-α Augments CXCR2 and CXCR3 to Promote Progression of Renal Cell Carcinoma

Journal of Cellular and Molecular Medicine
Molecular MedicineCell Biology
2016English

Cryptotanshinone Suppresses Cell Proliferation and Induces Apoptosis in Renal Cell Carcinoma as an STAT3 Inhibitor

Cancer Cell & Microenvironment
2018English

Inhibitors of SRC and Focal Adhesion Kinase Promote Endocrine Specification

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2011English

Downregulation of HSP60 Disrupts Mitochondrial Proteostasis to Promote Tumorigenesis and Progression in Clear Cell Renal Cell Carcinoma

Oncotarget
Oncology
2016English

Autophagy Inhibition and Antimalarials Promote Cell Death in Gastrointestinal Stromal Tumor (GIST)

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2010English

MicroRNA-424 Impairs Ubiquitination to Activate STAT3 and Promote Prostate Tumor Progression

Journal of Clinical Investigation
Medicine
2016English

The Tumor Marker for Renal Cell Carcinoma

Japanese Journal of Urology
Urology
1987English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy